Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246154.RApkJ_m9AbcdsVA3iQlr-nxaDJGYbkmhbywFYDf1b0Yz4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246154.RApkJ_m9AbcdsVA3iQlr-nxaDJGYbkmhbywFYDf1b0Yz4130_assertion type Assertion NP1246154.RApkJ_m9AbcdsVA3iQlr-nxaDJGYbkmhbywFYDf1b0Yz4130_head.
- NP1246154.RApkJ_m9AbcdsVA3iQlr-nxaDJGYbkmhbywFYDf1b0Yz4130_assertion description "[The early acquisition of TP53 mutations in the founding HSPC clone probably contributes to the frequent cytogenetic abnormalities and poor responses to chemotherapy that are typical of patients with t-AML/t-MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246154.RApkJ_m9AbcdsVA3iQlr-nxaDJGYbkmhbywFYDf1b0Yz4130_provenance.
- NP1246154.RApkJ_m9AbcdsVA3iQlr-nxaDJGYbkmhbywFYDf1b0Yz4130_assertion evidence source_evidence_literature NP1246154.RApkJ_m9AbcdsVA3iQlr-nxaDJGYbkmhbywFYDf1b0Yz4130_provenance.
- NP1246154.RApkJ_m9AbcdsVA3iQlr-nxaDJGYbkmhbywFYDf1b0Yz4130_assertion SIO_000772 25487151 NP1246154.RApkJ_m9AbcdsVA3iQlr-nxaDJGYbkmhbywFYDf1b0Yz4130_provenance.
- NP1246154.RApkJ_m9AbcdsVA3iQlr-nxaDJGYbkmhbywFYDf1b0Yz4130_assertion wasDerivedFrom befree-2016 NP1246154.RApkJ_m9AbcdsVA3iQlr-nxaDJGYbkmhbywFYDf1b0Yz4130_provenance.
- NP1246154.RApkJ_m9AbcdsVA3iQlr-nxaDJGYbkmhbywFYDf1b0Yz4130_assertion wasGeneratedBy ECO_0000203 NP1246154.RApkJ_m9AbcdsVA3iQlr-nxaDJGYbkmhbywFYDf1b0Yz4130_provenance.